| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.85▼ | 2.84▲ | 2.85▼ | 2.88▼ | 3.13▼ |
| MA10 | 2.85▼ | 2.86▼ | 2.86▼ | 3.07▼ | 2.84▼ |
| MA20 | 2.84▲ | 2.86▼ | 2.86▼ | 3.19▼ | 2.87▼ |
| MA50 | 2.85▼ | 2.86▼ | 2.99▼ | 2.85▼ | 4.20▼ |
| MA100 | 2.86▼ | 3.04▼ | 3.12▼ | 2.92▼ | 6.63▼ |
| MA200 | 2.86▼ | 3.13▼ | 3.09▼ | 3.49▼ | 6.93▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.002▼ | 0.009▲ | -0.073▼ | 0.159▲ |
| RSI | 47.434▼ | 44.567▼ | 42.282▼ | 44.276▼ | 43.089▼ |
| STOCH | 83.333▲ | 12.024▼ | 25.485 | 8.229▼ | 66.067 |
| WILL %R | -66.667 | -86.957▼ | -83.871▼ | -90.813▼ | -58.953 |
| CCI | 72.300 | -44.034 | -51.852 | -104.566▼ | 17.183 |
|
Wednesday, September 02, 2026 08:59 AM
On August 28, 2026, the Company filed its outstanding Form 10-Q filings for the second and third fiscal quarters of 2026 with the SEC. The Company is now in compliance with all Nasdaq listing ...
|
|
Wednesday, September 02, 2026 01:00 AM
Anavex Life Sciences has regained compliance with Nasdaq's listing rule for required periodic filings, the company said late Wednesday. The company filed its Form 10-Q reports for fiscal Q2 and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/09/26 | 2.925 | 2.94 | 2.825 | 2.84 | 352,482 |
| 02/09/26 | 2.88 | 2.978 | 2.815 | 2.89 | 587,400 |
| 01/09/26 | 2.79 | 2.90 | 2.755 | 2.87 | 826,629 |
| 31/08/26 | 2.96 | 2.97 | 2.78 | 2.80 | 1,033,081 |
| 28/08/26 | 3.12 | 3.13 | 2.96 | 2.99 | 893,286 |
| 27/08/26 | 3.248 | 3.26 | 3.12 | 3.13 | 652,495 |
| 26/08/26 | 3.50 | 3.54 | 3.22 | 3.24 | 1,177,197 |
| 25/08/26 | 3.408 | 3.6802 | 3.3651 | 3.56 | 2,472,725 |
| 24/08/26 | 3.20 | 3.22 | 3.09 | 3.11 | 414,093 |
| 21/08/26 | 3.18 | 3.285 | 3.16 | 3.24 | 480,685 |
|
|
||||
|
|
||||
|
|